The role of anti-IgE therapies in the treatment of asthma

被引:9
作者
Babu, KS [1 ]
Holgate, ST [1 ]
机构
[1] Southampton Gen Hosp, Dept Resp Cell & Mol Biol, Southampton SO16 6YD, Hants, England
来源
HOSPITAL MEDICINE | 2002年 / 63卷 / 08期
关键词
D O I
10.12968/hosp.2002.63.8.1969
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The prevalence of asthma, a chronic inflammatory disease often linked to allergy, is on the increase. The introduction of a blocking anti-IgE monoclonal antibody (omalizumab) as a new therapy has not only confirmed the pathogenic role of IgE in asthma but has also provided a novel therapy for a chronic severe disease where there are limited therapeutic options.
引用
收藏
页码:483 / 486
页数:4
相关论文
共 23 条
[1]   Omalizumab, a novel anti-IgE therapy in allergic disorders [J].
Babu, KS ;
Arshad, SH ;
Holgate, ST .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2001, 1 (06) :1049-1058
[2]   Anti-IgE treatment: an update [J].
Babu, KS ;
Arshad, SH ;
Holgate, ST .
ALLERGY, 2001, 56 (12) :1121-1128
[3]   Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response [J].
Boulet, LP ;
Chapman, KR ;
Cote, J ;
Kalra, S ;
Bhagat, R ;
Swystun, VA ;
Laviolette, M ;
Cleland, LD ;
Deschesnes, F ;
Su, JQ ;
DeVault, A ;
Fick, RB ;
Cockcroft, DW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) :1835-1840
[4]  
Busse WW, 2000, J ALLERGY CLIN IMMUN, V105, pS593
[5]   Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody [J].
Coyle, AJ ;
Wagner, K ;
Bertrand, C ;
Tsuyuki, S ;
Bews, J ;
Heusser, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1303-1310
[6]   The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects [J].
Fahy, JV ;
Fleming, HE ;
Wong, HH ;
Liu, JT ;
Su, JQ ;
Reimann, J ;
Fick, RB ;
Boushey, HA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1997, 155 (06) :1828-1834
[7]   Immunotherapy approach to allergic disease [J].
Fick, RB ;
Fox, JA ;
Jardieu, PM .
IMMUNOPHARMACOLOGY, 2000, 48 (03) :307-310
[8]  
Fox JA, 1996, J PHARMACOL EXP THER, V279, P1000
[9]  
HOLGATE S, 2001, AM J RESP CRIT CARE, V163, pA858
[10]  
HOLGATE S, 2001, AM J RESP CRIT CARE, V163, pS812